S190: ASXL1 MUTATIONS ACCELERATE BONE MARROW FIBROSIS VIA EGR1-TNFA AXIS MEDIATED INFLAMMATION AND FIBROCYTE GENERATION IN MYELOPROLIFERATIVE NEOPLASMS

S190: ASXL1 MUTATIONS ACCELERATE BONE MARROW FIBROSIS VIA EGR1-TNFA AXIS MEDIATED INFLAMMATION AND FIBROCYTE GENERATION IN MYELOPROLIFERATIVE NEOPLASMS

Bibliographic Details
Main Authors:	Z. Shi, J. Liu, Y. Zhao, L. Yang, Y. Cai, P. Zhang, Z. Xu, T. Qin, S. Qu, L. Pan, J. Wu, X. Yan, Z. Li, W. Zhang, Y. Yan, H. Huang, G. Huang, B. Li, X. Wu, Z. Xiao
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000843652.05474.21

Similar Items

Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish
by: Evisa Gjini, et al.
Published: (2019-05-01)

TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms
by: Nur Soyer, et al.
Published: (2017-05-01)

Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms
by: Yonal-Hindilerden I, et al.
Published: (2015-06-01)

Myeloproliferative neoplasms
by: Jean-Jacques Kiladjian
Published: (2018-06-01)

Myeloproliferative neoplasms
by: Nick Cross, (Coordinating Author)
Published: (2019-06-01)

Egr1 Knockdown Combined with an ACE Inhibitor Ameliorates Diabetic Kidney Disease in Mice: Blockade of Compensatory Renin Increase
by: Hu F, et al.
Published: (2020-04-01)

The microenvironment in myeloproliferative neoplasm
by: Simón Méndez-Ferrer, et al.
Published: (2018-06-01)

Spleen in myeloproliferative neoplasms
by: Giovanni Barosi
Published: (2018-06-01)

Aetiology of Myeloproliferative Neoplasms
by: Mary Frances McMullin, et al.
Published: (2020-07-01)

Epigenetics in myeloproliferative neoplasms
by: Graeme Greenfield, et al.
Published: (2023-07-01)

Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network
by: Yu-Kun Xia, et al.
Published: (2020-07-01)

Rare gene fusion rearrangement SPTNB1-PDGFRB in an atypical myeloproliferative neoplasm
by: Vanessa Fiorini Furtado, et al.
Published: (2018-10-01)

ABCA1 Exerts Tumor-Suppressor Function in Myeloproliferative Neoplasms
by: Manon Viaud, et al.
Published: (2020-03-01)

P1004: EFFECT AND MOLECULAR MECHANISM OF TQ05105, A NOVEL SMALL MOLECULE INHIBITOR OF JAK2 IN MYELOPROLIFERATIVE NEOPLASM
by: W. Zhang, et al.
Published: (2022-06-01)

The emerging role of fibrocytes in ocular disorders
by: Feng Zhang, et al.
Published: (2018-04-01)

METABOLIC PROFILE OF BONE MARROW PLASMA IN MYELOPROLIFERATIVE NEOPLASMS
by: MC Cacemiro, et al.
Published: (2021-10-01)

Myeloproliferative neoplasm stem cells
by: Mead, A, et al.
Published: (2017)

Mutant Calreticulin in the Myeloproliferative Neoplasms
by: Daniel Prins, et al.
Published: (2020-02-01)

Interferons in the treatment of myeloproliferative neoplasms
by: Pankit Vachhani, et al.
Published: (2024-02-01)

Neurological Findings in Myeloproliferative Neoplasms
by: Semra Paydas
Published: (2013-04-01)

Novel therapeutics in myeloproliferative neoplasms
by: Sangeetha Venugopal, et al.
Published: (2020-12-01)

Targeted therapies for myeloproliferative neoplasms
by: Bing Li, et al.
Published: (2019-07-01)

CALR Mutations in Myeloproliferative Neoplasms
by: Ken-Hong Lim
Published: (2014-06-01)

Molecular Progression of Myeloproliferative and Myelodysplastic/Myeloproliferative Neoplasms: A Study on Sequential Bone Marrow Biopsies
by: Magdalena M. Brune, et al.
Published: (2021-11-01)

Genomic trajectory in leukemogenesis of myeloproliferative neoplasms: a case report
by: Yujie Chen, et al.
Published: (2021-05-01)

Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
by: Bing Li, et al.
Published: (2017-05-01)

The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms.
by: Yan Chen, et al.
Published: (2016-01-01)

Classification and personalized prognosis in myeloproliferative neoplasms
by: Grinfeld, J, et al.
Published: (2018)

Thrombosis and hemorrhage in myeloproliferative neoplasms: The platelet perspective
by: Yiming Feng, et al.
Published: (2022-10-01)

Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
by: Pecquet, C, et al.
Published: (2022)

Incidence in PH-negative myeloproliferative neoplasms in armenia from 2005 to 2019
by: L. Sahakyan, et al.
Published: (2020-10-01)

ASXL1/2 mutations and myeloid malignancies
by: Edward A. Medina, et al.
Published: (2022-09-01)

Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India
by: Nikhil Rabade, et al.
Published: (2018-01-01)

Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms
by: Vasundhara Sharma, et al.
Published: (2020-11-01)

Heterogeneity in myeloproliferative neoplasms: causes and consequences
by: O'Sullivan, J, et al.
Published: (2018)

Mechanisms of disease transformation in myeloproliferative neoplasms
by: O'Sullivan, J
Published: (2022)

Functional Consequences of Mutations in Myeloproliferative Neoplasms
by: Stefan N. Constantinescu, et al.
Published: (2021-06-01)

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
by: Laura Palomo, et al.
Published: (2021-04-01)

Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
by: Lasse Kjær
Published: (2020-07-01)

NK Cells in Myeloproliferative Neoplasms (MPN)
by: Erin Naismith, et al.
Published: (2021-08-01)